相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells
Roya Sarkhosh-Inanlou et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2020)
Synthetic Lethality Screening Identifies FDA-Approved Drugs That Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
Marta Mariniello et al.
CANCERS (2020)
Drug-metabolizing enzymes: role in drug resistance in cancer
G. Kaur et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer
David Lukanovic et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies
Archu Singh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1
Anastasia De Luca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Improved efficacy of naproxen-loaded NLC for temporomandibular joint administration
Viviane A. Guilherme et al.
SCIENTIFIC REPORTS (2019)
ROS as a novel indicator to predict anticancer drug efficacy
Tarek Zaidieh et al.
BMC CANCER (2019)
Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy
Yue-Qin Li et al.
IUBMB LIFE (2018)
Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance
Xiang Ling et al.
NANO LETTERS (2018)
The role of cellular reactive oxygen species in cancer chemotherapy
Haotian Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis
Flavia Biamonte et al.
CELL DEATH & DISEASE (2018)
Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer
Nicole M. Fletcher et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis
Vijay Kumar et al.
PHARMACEUTICAL RESEARCH (2017)
Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding
Huifang Peng et al.
ONCOTARGET (2017)
A systematic in vitro investigation on poly-arginine modified nanostructured lipid carrier: Pharmaceutical characteristics, cellular uptake, mechanisms and cytotoxicity
Mingshuang Sun et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Development and optimization of ifosfamide nanostructured lipid carriers for oral delivery using response surface methodology
Ramaiyan Velmurugan et al.
APPLIED NANOSCIENCE (2016)
Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes
Kurtulus Gokduman
CURRENT DRUG TARGETS (2016)
Mitochondrial ROS regulation of proliferating cells
Lauren Diebold et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation
Ankita Leekha et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
ROS homeostasis and metabolism: a dangerous liason in cancer cells
E. Panieri et al.
CELL DEATH & DISEASE (2016)
Cancer drug resistance: redox resetting renders a way
Yuan Liu et al.
ONCOTARGET (2016)
Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study
Nirmal V. Shah et al.
JOURNAL OF ADVANCED RESEARCH (2016)
APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
N. Mohell et al.
CELL DEATH & DISEASE (2015)
Antioxidant responses and cellular adjustments to oxidative stress
Cristina Espinosa-Diez et al.
REDOX BIOLOGY (2015)
Gene Expression Analysis in MCF-7 Breast Cancer Cells Treated with Recombinant Bromelain
Nour Fouz et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2014)
Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines
L. Sawers et al.
BRITISH JOURNAL OF CANCER (2014)
Pluronics and MDR Reversal: An Update
Daria Y. Alakhova et al.
MOLECULAR PHARMACEUTICS (2014)
Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients
Hyery Kim et al.
CHILDS NERVOUS SYSTEM (2013)
Engineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: Physicochemical investigations
Dipak D. Kumbhar et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2013)
An international assessment of ovarian cancer incidence and mortality
Kimberly A. Lowe et al.
GYNECOLOGIC ONCOLOGY (2013)
Development of chitosan-based dry powder inhalation system of cisplatin for lung cancer
MalaD Menon et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Role of Glutathione in Cancer Progression and Chemoresistance
Nicola Traverso et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
Rossella Marullo et al.
PLOS ONE (2013)
Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
Xiaoyang Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Beyond oxidative stress: an immunologist's guide to reactive oxygen species
Carl Nathan et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Augmentation of anti-tumour activity of cisplatin by pectin nano-conjugates in B-16 mouse model: pharmacokinetics and in-vivo biodistribution of radio-labelled, hydrophilic nano-conjugates
Anita Kamra Verma et al.
INTERNATIONAL JOURNAL OF NANOTECHNOLOGY (2012)
Nanostructured lipid carriers system: Recent advances in drug delivery
Md Asif Iqbal et al.
JOURNAL OF DRUG TARGETING (2012)
Magnetite induces oxidative stress and apoptosis in lung epithelial cells
Vani Ramesh et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
Jewel L. Podratz et al.
NEUROBIOLOGY OF DISEASE (2011)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Reactive oxygen species in cancer
Geou-Yarh Liou et al.
FREE RADICAL RESEARCH (2010)
Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug
Karoline Leonhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glutathione: Overview of its protective roles, measurement, and biosynthesis
Henry Jay Forman et al.
MOLECULAR ASPECTS OF MEDICINE (2009)
A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment
Lin Mei et al.
NANOSCALE RESEARCH LETTERS (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
Ganna V. Kalayda et al.
BMC CANCER (2008)
Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons
Yanlin Jiang et al.
CANCER RESEARCH (2008)
αvβ3 integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species
Anamaria Brozovic et al.
MOLECULAR PHARMACOLOGY (2008)
Transport of cisplatin by the copper efflux transporter ATP7B
Roohangiz Safaei et al.
MOLECULAR PHARMACOLOGY (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria
N. A. G. Santos et al.
ARCHIVES OF TOXICOLOGY (2007)
Oxidative stress and apoptosis: impact on cancer therapy
Tomris Ozben
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: Possible role in apoptosis
Zejia Yang et al.
CLINICAL CANCER RESEARCH (2006)
Role of mitochondrial DNA in toxic responses to oxidative stress
B Van Houten et al.
DNA REPAIR (2006)
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells
G Samimi et al.
CLINICAL CANCER RESEARCH (2004)
Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells
K Katano et al.
CLINICAL CANCER RESEARCH (2004)
Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85
EV Batrakova et al.
PHARMACEUTICAL RESEARCH (2003)
Glutathione peroxidase-1 protects from CD95-induced apoptosis
V Gouazé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
分享论文
